Hamamatsu University School of Medicine · Department of First Internal Medicine · 特任准教授

Research keywords膜性腎症・Onconephrology・ドラッグ・リポジショニング・ネフローゼ症候群・急性腎障害

This is a public-data preview. Personalized fit, contact angles, and saved workflows require sign-in.

• Teneligliptin and empagliflozin attenuate ferroptosis-mediated acute tubular injury2025 · NEPHROLOGY DIALYSIS TRANSPLANTATION （2025年） [査読] 有
• Patient's view on: "Low-protein diet with personalized support in advanced chronic kidney disease: association with disease progression, dialysis delay, and mortality"2025 · Clinical Kidney Journal （2025年） [査読] 有
• Tubular Epithelial Cell HMGB1 Promotes AKI-CKD Transition by Sensitizing Cycling Tubular Cells to Oxidative Stress: A Rationale for Targeting HMGB1 during AKI Recovery.2023 · Journal of the American Society of Nephrology : JASN [巻]34 [号]3 [頁]394 -411 （2023年） [査読] 有
• A Diagnostic and Therapeutic Dilemma Concerning Exostosin 1/Exostosin 2-associated Lupus-like Membranous Nephropathy with Positive Anti-nuclear Antibody in an Elderly Man with Various Immune Abnormalities.2023 · Internal medicine (Tokyo, Japan) （2023年） [査読] 有

• Mg欠乏モデルを用いたDPP4阻害薬のシスプラチン腎症軽減効果の機序解明
• Dipeptidyl peptidase-4 (DPP-4)阻害薬による腎尿細管障害予防および障害後再生促進効果についての検討
• DPP4阻害薬によるシスプラチンの抗癌作用への影響と腎障害軽減機序の解明
• 細胞系譜解析による腎保護および再生治療戦略の検討

• Official profile